Last reviewed · How we verify
Medical Grade Oxygen
At a glance
| Generic name | Medical Grade Oxygen |
|---|---|
| Also known as | oxygen |
| Sponsor | Hal C Charles |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments (NA)
- Methemoglobin Concentration in High Dose Inhaled Nitric Oxide (EARLY_PHASE1)
- NASA Prebreathe Study (PHASE1)
- Wearable Assessment of Thoracic, Cardiac Health and Exercise Performance Trial
- The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease. (PHASE1, PHASE2)
- Inhaled Nitric Oxide (iNO) in Idiopathic Pulmonary Fibrosis (IPF). (EARLY_PHASE1)
- Inhaled Nitric Oxide (iNO) in Post-Pulmonary Embolism (Post-PE) (NA)
- Biological Markers for Post-Traumatic Stress Disorder
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Medical Grade Oxygen CI brief — competitive landscape report
- Medical Grade Oxygen updates RSS · CI watch RSS
- Hal C Charles portfolio CI